T1	Intervention 14 58	prophylactic calcium and magnesium infusions
T2	Intervention 805 917	treatment with capecitabine, oxaliplatin and bevacizumab or the same combination with the addition of cetuximab.
T3	Intervention 961 1107	two groups: patients in the Ca/Mg(+) group received Ca/Mg at least during their first treatment cycle, and patients in the Ca/Mg(-) group did not.
T4	Intervention 1857 1871	neurotoxicity.
T5	Intervention 1872 1887	Ca/Mg infusions
